Physician profile
Patrick B Pyron
NPI 1245423763
$1,081.53
in general payments reported to CMS, 2019-2025
10 companies · $74.51 in 2025
The $74.51 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.62 · 2020: $63.56 · 2021: $477 · 2022: $269 · 2023: $120 · 2024: $44.24 · 2025: $74.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $517.06 | 2020-2025 | Precision 1, Total30, Precision7 |
| Eyevance Pharmaceuticals LLC | $175.98 | 2020-2021 | |
| Johnson & Johnson Vision Care, INC. | $123.59 | 2019-2024 | Acuvue |
| Abbvie INC. | $103.16 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $44.75 | 2023 | Amo Phaco Needle |
| Oyster Point Pharma, INC. | $29.60 | 2022 | |
| Novartis Pharmaceuticals Corporation | $26.97 | 2022-2023 | |
| Allergan, INC. | $23.93 | 2022 | |
| Bausch & Lomb Americas INC. | $18.73 | 2025 | Xiidra, Miebo |
| Dompe US, INC. | $17.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Pyron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.